{"id":"https://openalex.org/W3141139771","doi":"https://doi.org/10.1136/jitc-2020-002173","title":"Fully human antibody VH domains to generate mono and bispecific CAR to target solid tumors","display_name":"Fully human antibody VH domains to generate mono and bispecific CAR to target solid tumors","publication_year":2021,"publication_date":"2021-04-01","ids":{"openalex":"https://openalex.org/W3141139771","doi":"https://doi.org/10.1136/jitc-2020-002173","mag":"3141139771","pmid":"https://pubmed.ncbi.nlm.nih.gov/33795386","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8021891"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2020-002173","doi":"https://doi.org/10.1136/jitc-2020-002173","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2020-002173","pdf_url":"https://jitc.bmj.com/content/jitc/9/4/e002173.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/4/e002173.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012468124","display_name":"Guanmeng Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guanmeng Wang","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100424230","display_name":"Xin Zhou","orcid":"https://orcid.org/0000-0001-9281-3612","observed_orcids":["https://orcid.org/0000-0001-9281-3612"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Zhou","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0001-9281-3612","affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000073229","display_name":"Giovanni Fuc\u00e0","orcid":"https://orcid.org/0000-0002-1560-2253","observed_orcids":["https://orcid.org/0000-0002-1560-2253"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giovanni Fuc\u00e0","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015594479","display_name":"Elena Dukhovlinova","orcid":"https://orcid.org/0000-0002-2094-2543","observed_orcids":["https://orcid.org/0000-0002-2094-2543"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Dukhovlinova","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058775810","display_name":"Peishun Shou","orcid":"https://orcid.org/0000-0001-7685-7471","observed_orcids":["https://orcid.org/0000-0001-7685-7471"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peishun Shou","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0001-7685-7471","affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hongxia Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongxia Li","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025943143","display_name":"Colette M. Johnston","orcid":"https://orcid.org/0000-0002-7823-5104","observed_orcids":["https://orcid.org/0000-0002-7823-5104"]},"institutions":[{"id":"https://openalex.org/I4405264799","display_name":"Crescendo Biologics Ltd. (United Kingdom)","ror":"https://ror.org/0304xfx24","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405264799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Colette Johnston","raw_affiliation_strings":["Crescendo Biologics Ltd, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crescendo Biologics Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4405264799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046138823","display_name":"Brian McGuinness","orcid":"https://orcid.org/0009-0002-3337-1302","observed_orcids":["https://orcid.org/0009-0002-3337-1302"]},"institutions":[{"id":"https://openalex.org/I4405264799","display_name":"Crescendo Biologics Ltd. (United Kingdom)","ror":"https://ror.org/0304xfx24","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405264799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Brian Mcguinness","raw_affiliation_strings":["Crescendo Biologics Ltd, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crescendo Biologics Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4405264799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023649972","display_name":"Gianpietro Dotti","orcid":"https://orcid.org/0000-0002-2639-8526","observed_orcids":["https://orcid.org/0000-0002-2639-8526"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gianpietro Dotti","raw_affiliation_strings":["Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056029681","display_name":"Hongwei Du","orcid":"https://orcid.org/0000-0002-7997-4507","observed_orcids":["https://orcid.org/0000-0002-7997-4507"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hongwei Du","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0002-7997-4507","affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5023649972","https://openalex.org/A5056029681"],"corresponding_institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":1.4243,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.84351785,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"9","issue":"4","first_page":"e002173","last_page":"e002173"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.968999981880188},{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":1.0},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7699999809265137},{"id":"https://openalex.org/keywords/tumor-antigen-heterogeneity","display_name":"tumor antigen heterogeneity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/tumor-escape","display_name":"tumor escape","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.7562520503997803},{"id":"https://openalex.org/C2776967038","wikidata":"https://www.wikidata.org/wiki/Q290671","display_name":"Single-chain variable fragment","level":4,"score":0.708173930644989},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6810951232910156},{"id":"https://openalex.org/C2777045440","wikidata":"https://www.wikidata.org/wiki/Q14914057","display_name":"Mesothelin","level":3,"score":0.6691330075263977},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5851300954818726},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5848944187164307},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5638282895088196},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5336160659790039},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5028819441795349},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.4567195177078247},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4458228647708893},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4377751350402832},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3322795033454895},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30684804916381836},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30205321311950684},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23957201838493347},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.20180171728134155},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08348754048347473},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000090204","descriptor_name":"Mesothelin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000954","descriptor_name":"Antigens, Surface","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007135","descriptor_name":"Immunoglobulin Variable Region","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007135","descriptor_name":"Immunoglobulin Variable Region","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000637","qualifier_name":"transplantation","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016688","descriptor_name":"Mice, Inbred NOD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018920","descriptor_name":"Coculture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043425","descriptor_name":"Glutamate Carboxypeptidase II","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057127","descriptor_name":"Single-Chain Antibodies","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D057127","descriptor_name":"Single-Chain Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1136/jitc-2020-002173","doi":"https://doi.org/10.1136/jitc-2020-002173","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2020-002173","pdf_url":"https://jitc.bmj.com/content/jitc/9/4/e002173.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8021891","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8021891","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:33795386","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33795386","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Comparative Study"},{"id":"pmh:cdr.lib.unc.edu:r207v074z","doi":null,"is_oa":false,"landing_page_url":"https://doi.org/10.17615/v4m2-m188","pdf_url":null,"source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, 9(4)","raw_type":"Article"},{"id":"pmh:oai:doaj.org/article:6d702eedfb2a4f718ee30f72bdc6dba2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6d702eedfb2a4f718ee30f72bdc6dba2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)","raw_type":"article"},{"id":"doi:10.17615/v4m2-m188","doi":"https://doi.org/10.17615/v4m2-m188","is_oa":true,"landing_page_url":"https://doi.org/10.17615/v4m2-m188","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.1136/jitc-2020-002173","doi":"https://doi.org/10.1136/jitc-2020-002173","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2020-002173","pdf_url":"https://jitc.bmj.com/content/jitc/9/4/e002173.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.979200005531311,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1577013656","display_name":null,"funder_award_id":"R01-CA193140","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1820400879","display_name":"Cellular Immunotherapy of Ovarian Cancer","funder_award_id":"R01CA243543","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2622192207","display_name":"TARGETING B7-H3 IN METASTATIC RENAL CELL CARCINOMA USING CAR-T CELLS","funder_award_id":"W81XWH1810441","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G4119534169","display_name":null,"funder_award_id":"W81XWH","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G440106645","display_name":"Targeting the Ig-light chains with CAR-T cells in lymphoid tumors","funder_award_id":"5r01ca193140-05","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G534517478","display_name":null,"funder_award_id":"P30-CA016086","funder_id":"https://openalex.org/F4320332600","funder_display_name":"University of North Carolina at Chapel Hill"},{"id":"https://openalex.org/G7366156696","display_name":null,"funder_award_id":"CA016086","funder_id":"https://openalex.org/F4320337594","funder_display_name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill"},{"id":"https://openalex.org/G8118727525","display_name":null,"funder_award_id":"R01-CA193140-03","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8166743225","display_name":null,"funder_award_id":"W81XWH-18","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G9000913976","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016086","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G958207224","display_name":null,"funder_award_id":"P30-CA016086","funder_id":"https://openalex.org/F4320337594","funder_display_name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332600","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337594","display_name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3141139771.pdf","grobid_xml":"https://content.openalex.org/works/W3141139771.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1574443686","https://openalex.org/W1926256541","https://openalex.org/W1965185692","https://openalex.org/W1977949161","https://openalex.org/W1993575340","https://openalex.org/W1997463594","https://openalex.org/W1999671728","https://openalex.org/W2010607826","https://openalex.org/W2014158928","https://openalex.org/W2021256658","https://openalex.org/W2028460943","https://openalex.org/W2066104588","https://openalex.org/W2079846411","https://openalex.org/W2085845614","https://openalex.org/W2095553811","https://openalex.org/W2095692889","https://openalex.org/W2124513722","https://openalex.org/W2154543415","https://openalex.org/W2372842761","https://openalex.org/W2468307583","https://openalex.org/W2567424265","https://openalex.org/W2580377636","https://openalex.org/W2616637874","https://openalex.org/W2738678436","https://openalex.org/W2766453934","https://openalex.org/W2770704851","https://openalex.org/W2783925321","https://openalex.org/W2785898023","https://openalex.org/W2887712828","https://openalex.org/W2907190120","https://openalex.org/W2913654179","https://openalex.org/W2919051790","https://openalex.org/W2921832117","https://openalex.org/W2921917792","https://openalex.org/W2949945804","https://openalex.org/W2966732164","https://openalex.org/W2979821561","https://openalex.org/W2994525341","https://openalex.org/W2999579353","https://openalex.org/W3003850371","https://openalex.org/W3005412445","https://openalex.org/W3007310264","https://openalex.org/W3017694018","https://openalex.org/W3044350523","https://openalex.org/W3151257693","https://openalex.org/W6776257846","https://openalex.org/W7074041926"],"related_works":["https://openalex.org/W4414103679","https://openalex.org/W2792466561","https://openalex.org/W2914124133","https://openalex.org/W3165502315","https://openalex.org/W2935922554","https://openalex.org/W3040089074","https://openalex.org/W4408335203","https://openalex.org/W4224248906","https://openalex.org/W4288457671","https://openalex.org/W2927684362"],"abstract_inverted_index":{"Background":[0],"Chimeric":[1],"antigen":[2,14,17,87,185],"receptor":[3],"(CAR)":[4],"T":[5,97,203],"cells":[6,204,230],"are":[7,137,153],"effective":[8],"in":[9,25,117,120,142,145,149,181,208,247],"B-cell":[10],"malignancies.":[11],"However,":[12],"heterogeneous":[13,184],"expression":[15],"and":[16,90,95,105,112,119,135,139,144,201,241],"loss":[18],"remain":[19],"important":[20],"limitations":[21],"of":[22,40,48,60,107,109,155],"targeted":[23],"immunotherapy":[24],"solid":[26,209,248],"tumors.":[27,249],"Therefore,":[28],"targeting":[29,59,133],"multiple":[30,61],"tumor-associated":[31],"antigens":[32,62,236],"simultaneously":[33,232],"is":[34],"expected":[35],"to":[36,45,55,81,196,226,231],"improve":[37],"the":[38,46,57,124,150],"outcome":[39],"CAR-T":[41,229],"cell":[42,98],"therapies.":[43],"Due":[44],"instability":[47],"single-chain":[49,65],"variable":[50,67],"fragments,":[51],"it":[52],"remains":[53],"challenging":[54],"develop":[56],"simultaneous":[58],"using":[63],"traditional":[64,125],"fragment":[66],"(scFv)-based":[68],"CARs.":[69,127,218],"Methods":[70],"We":[71],"used":[72,195,225],"Humabody":[73],"VH":[74,89,93,100,111,114,130,147,175,191,221],"domains":[75,176,192,222],"derived":[76],"from":[77],"a":[78],"transgenic":[79],"mouse":[80],"obtain":[82],"fully":[83],"human":[84,173,189],"prostate-specific":[85],"membrane":[86],"(PSMA)":[88],"mesothelin":[91],"(MSLN)":[92],"sequences":[94],"redirect":[96],"with":[99,123,160,183],"based-CAR.":[101],"The":[102],"antitumor":[103],"activity":[104],"mode":[106],"action":[108],"PSMA":[110,134],"MSLN":[113,136],"were":[115],"evaluated":[116],"vitro":[118,143],"vivo":[121],"compared":[122],"scFv-based":[126,217],"Results":[128],"Human":[129],"domain-based":[131],"CAR":[132,199],"stable":[138],"functional":[140,198],"both":[141],"vivo.":[146],"modules":[148],"bispecific":[151,228],"format":[152],"capable":[154],"binding":[156],"their":[157,164],"specific":[158],"target":[159,233],"similar":[161],"affinity":[162],"as":[163,213,215],"monovalent":[165],"counterparts.":[166],"Bispecific":[167],"CARs":[168],"generated":[169],"by":[170,238],"joining":[171],"two":[172,234],"antibody":[174,190],"can":[177,193,223],"prevent":[178],"tumor":[179,182,239,245],"escape":[180],"expression.":[186],"Conclusions":[187],"Fully":[188],"be":[194,224],"generate":[197,227],"molecules,":[200],"redirected":[202],"elicit":[205],"antitumoral":[206],"responses":[207],"tumors":[210],"at":[211],"least":[212],"well":[214],"conventional":[216],"In":[219],"addition,":[220],"different":[235],"expressed":[237],"cells,":[240],"therefore,":[242],"achieve":[243],"better":[244],"control":[246]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2021-04-13T00:00:00"}